However, as they are not FDA approved and have not been vetted in long-term trials there is no way to guarantee their safety, efficacy or potency. Now, as drug manufacturers successfully push the FDA to remove semaglutide and tirzepatide from the shortage list, access to compounded versions may soon disappear
Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans
Corneal endothelial cells provide evidence of accelerated cellular senescence associated with HIV infection: a case-control study
Back Vecchio, i, Tornali, C, Bragazzi, NL, et al (23 Oct 2018) 'The Discovery of Insulin: An important milestone in the history of medicine', Frontiers in Endocrinology , 9, 613
Additional safety considerations include risk of dehydration and acute kidney injury, potential worsening of diabetic retinopathy with rapid glucose improvement (particularly with semaglutide), and hypoglycemia risk when combined with insulin or sulfonylureas
